Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
82.84 USD | -3.69% | -6.49% | -31.97% |
07:43pm | Sector Update: Financial Stocks Edge Up Tuesday Afternoon | MT |
07:27pm | Sector Update: Financial | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- The group shows a rather high level of debt in proportion to its EBITDA.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-31.97% | 7.94B | B- | ||
+12.66% | 110B | B | ||
+21.74% | 108B | B- | ||
-7.94% | 93.53B | B+ | ||
+22.97% | 73.99B | D+ | ||
+24.89% | 36.08B | B | ||
+15.48% | 30.16B | B | ||
+12.50% | 29.77B | A | ||
-0.21% | 17.31B | C+ | ||
-12.54% | 14.7B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- GL Stock
- Ratings Globe Life Inc.